Navigation Links
EntreMed Announces FDA Acceptance of IND Application for Aurora Kinase/Angiogenesis Inhibitor, ENMD-2076
Date:1/3/2008

ROCKVILLE, Md., Jan. 3 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for its aurora kinase/angiogenesis inhibitor, ENMD-2076.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO )

ENMD-2076 is a novel, dual-acting, kinase inhibitor with potent activity against Aurora A and tyrosine kinases linked to promoting cancer and inflammatory diseases. ENMD-2076 acts through multiple pathways resulting in antiproliferative activity and the inhibition of angiogenesis. ENMD-2076 has demonstrated substantial, dose-dependent efficacy as a single agent in multiple xenograft models, including tumor regression in breast, colon, and leukemia models. Importantly, ENMD-2076 is an oral agent that has shown an acceptable toxicity profile in preclinical studies without cardiovascular effects.

Carolyn F. Sidor, MD, MBA, EntreMed Vice President and Chief Medical Officer commented on the IND, "Acceptance of the Investigational New Drug application for ENMD-2076 initiates the clinical program for our first compound that targets kinases. This is an exciting class of compounds with several recently approved in oncology indications. ENMD-2076 is unique in class because it not only inhibits Aurora A selectively over Aurora B, it also inhibits a number of other kinases important in the growth of tumors and, in particular, growth factor receptors critical to angiogenesis. ENMD-2076 has potent antitumor activity
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. EntreMed to Present at ThinkEquity Partners 5th Annual Growth Conference
2. EntreMed Appoints Senior Vice President of Research and Development
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... On April 19th the Center for Disease ... the growing antibiotic resistant bacteria that may be lurking ... study were released late last month showing higher antibiotic ... years. For those suffering from bacteria driven acne, Probiotic ... in food, may eventually help breed acne causing bacteria. ...
(Date:5/23/2013)... Z Trim Holdings, Inc. (OTC Markets: ZTHO), ... of industries, announced that Chef Erin Ryan ... year,s National Restaurant Association ("NRA") NRA Show, which was ... Research Chefs Association.  Chef Ryan spoke on the subject ... and the Ugly," joining four other prestigious panelists including: ...
(Date:5/23/2013)... 2013 Northwest Biotherapeutics (NASDAQ: NWBO ... personalized immune therapies for solid tumor cancers, announced ... year,s American Society Of Clinical Oncology (ASCO) meeting in ... role in immune therapy.  (Logo: http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ... the pre-eminent conference focused on clinical treatment of cancer, ...
(Date:5/23/2013)... DC (PRWEB) May 23, 2013 The ... in STEM industries, Black Data Processing Associates (BDPA), is ... on June 8, 2013. This all-day event will encourage ... and learn the ins and outs from many of ... 3 p.m. at the New Jersey Institute of Technology, ...
Breaking Biology Technology:Acne Cream, Probiotic Action Shares News on How Some Food may Breed Acne Causing Bacteria 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 2Z Trim's Chef Erin Ryan sits on Expert Panel at NRA Show 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Black Data Processing Associates (BDPA) New Jersey Hosts 10th Annual Families in Technology Day June 8, 2013 2
... YORK, May 26, 2011 Reportlinker.com announces ... available in its catalogue: ... http://www.reportlinker.com/p0511976/Future-Directions-in-Regenerative-Medicine.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Biological_Therapy Big ... Genzyme in 2008, Pfizer and Novartis in ...
... MicroConstants China Inc., a Contract Research Organization (CRO) ... clinical trial management in Beijing , announces the ... Good Laboratory Practice (GLP) in the areas of analytical ... Compliance Monitoring Programme . MicroConstants China is the first ...
... Our understanding of what differentiates cancer cells from normal cells ... complex signal systems of individual cells. By combing two different ... research world with a tool for studying signal paths on ... published today in PLoS One . "We also ...
Cached Biology Technology:Reportlinker Adds Future Directions in Regenerative Medicine 2Reportlinker Adds Future Directions in Regenerative Medicine 3Reportlinker Adds Future Directions in Regenerative Medicine 4Reportlinker Adds Future Directions in Regenerative Medicine 5Reportlinker Adds Future Directions in Regenerative Medicine 6MicroConstants China Receives Endorsement of OECD GLP Compliance 2Combo method reveals cells' signal systems 2
(Date:5/21/2013)... The concept of "place" is increasingly being considered ... now have a new resource that can help ... have with the places in their lives. ... a new book co-edited by the Pacific Northwest ... a human-centered approach to conservation. The book is ...
(Date:5/21/2013)... When infections occur in the body, stem cells ... multiplying and differentiating into mature immune cells that ... inflammation can deplete these cell populations, potentially leading ... as cancer. Now, a team of researchers led ... (Caltech) has found that, in mouse models, the ...
(Date:5/21/2013)... researchers have developed a new method for delivering ... in the cell surface. The technique could find ... biological fields. , Bulk electroporation a technique ... nanopores in the cell membrane that are caused ... an increasingly popular method of cell transfection. (Cell ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Single-cell transfection tool enables added control for biological studies 2
... If the growing presence of computer ,geeks, on television ... essential tools for detecting and combating skullduggery. However, television ... these tools. Researchers also are beginning to collaborate with ... known as molecular mimicry. "Molecular mimicry is ...
... Eczema patients at risk for serious viral infections ... allergic to food and other allergens, and have a ... National Jewish Health and other institutions in the NIH-funded ... in the online version of The Journal of ...
... insights into the early evolution of the estrogen receptor, research ... School of Medicine may lead to a contraceptive for female ... in the Great Lakes region of the United States. ... where lampreys aggressively consume trout, salmon, sturgeon and other game ...
Cached Biology News:Computers aid in cracking deception in plants 2Study characterizes eczema patients most at risk for dangerous viral infections 2Study characterizes eczema patients most at risk for dangerous viral infections 3Evolution of a contraceptive for sea lamprey 2
Request Info...
... Processing Standard Tray (3 per pack), ... staining and blot processing.Automated staining of ... proteins and nucleic acid analysis.Prepares blots ... chromogenic detection.Programmable control of protocol, solution, ...
L1 Protein of Human Papilloma Virus Purified Anti-Viral-transformed cells clone CAMVIR-1, Isotype Mouse IgG 2a , 0.1 mg Consult technical datasheet for details....
75 x 25 mm; sterile, recommended for immunohistochemistry of cell lines growing in suspension, Poly-D-Lysine coated, glass slides with polystyrene vessel, lid and safety removal tool...
Biology Products: